HEAD AND NECK CANCER
Clinical trials for HEAD AND NECK CANCER explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CANCER trials appear
Sign up with your email to follow new studies for HEAD AND NECK CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to stop HPV-Related head and neck cancer from coming back
Disease control Not yet recruitingThis study tests whether adding fianlimab to the standard drug cemiplimab can better prevent cancer from returning in people with HPV-positive head and neck cancer who have tiny amounts of cancer still detectable after initial treatment. About 68 adults will receive either cemipl…
Matched conditions: HEAD AND NECK CANCER
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 16, 2026 23:47 UTC
-
New study aims to save smiles after head and neck cancer treatment
Disease control Not yet recruitingThis study tests whether extra dental support for head and neck cancer survivors can prevent or reduce late side effects like tooth loss, jaw stiffness, and cavities. About 300 adults who finished cancer treatment will receive an oral care program every three months for three yea…
Matched conditions: HEAD AND NECK CANCER
Phase: NA • Sponsor: Uppsala University • Aim: Disease control
Last updated May 16, 2026 23:38 UTC
-
New combo aims to tame head and neck cancer
Disease control Not yet recruitingThis study tests a combination of the immunotherapy drug toripalimab with two chemotherapy drugs (cisplatin and docetaxel) as an initial treatment for people with advanced head and neck cancer that has a specific marker (CPS-positive). The goal is to see if this combination is sa…
Matched conditions: HEAD AND NECK CANCER
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New drug cocktail aims to shrink oral tumors before surgery
Disease control Not yet recruitingThis study tests whether giving a combination of two drugs (XL-092 and pembrolizumab) before surgery can shrink tumors in people with a type of mouth cancer called oral cavity squamous cell carcinoma. The trial will include 26 adults whose cancer has not spread too far and is HPV…
Matched conditions: HEAD AND NECK CANCER
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug 'Unmasks' cancer cells to immune system in early trial
Disease control Not yet recruitingThis early-phase trial tests a new drug that helps the immune system recognize and attack cancer cells by blocking a 'don't eat me' signal. It is for people with advanced solid tumors that have not responded to standard treatments. The main goal is to check safety and find the ri…
Matched conditions: HEAD AND NECK CANCER
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New immune drug targets Hard-to-Treat cancers in early trial
Disease control Not yet recruitingThis early-phase study tests a new drug, CRPA1A2, that helps the immune system attack cancer cells. It is for people with certain advanced solid tumors (like lung, esophagus, head and neck, or liver cancer) who have a specific genetic marker (HLA-A*02:01 and MAGE-A1). The main go…
Matched conditions: HEAD AND NECK CANCER
Phase: PHASE1 • Sponsor: Corregene Biotechnology Co., Ltd • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New scan could spare cancer patients from unnecessary radiation side effects
Disease control Not yet recruitingThis study looks at whether a special scan called SPECT-CT can help doctors decide to treat only one side of the neck with radiation in people with oropharyngeal cancer. Currently, both sides are treated to prevent hidden cancer spread, but this causes more side effects. The tria…
Matched conditions: HEAD AND NECK CANCER
Phase: NA • Sponsor: UNICANCER • Aim: Disease control
Last updated May 07, 2026 18:42 UTC
-
Experimental combo aims to boost immune attack on Hard-to-Treat head and neck cancer
Disease control Not yet recruitingThis early-phase study tests a combination of two drugs—decitabine (a chemotherapy that can 'reawaken' genes) and nivolumab (an immunotherapy that helps the immune system fight cancer)—in people with head and neck cancer that has returned or spread and cannot be cured with local …
Matched conditions: HEAD AND NECK CANCER
Phase: PHASE1 • Sponsor: Kyunghee Burkitt, DO, PhD • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Can a skin cell spray give cancer patients a more natural look after surgery?
Symptom relief Not yet recruitingThis study tests whether using RECELL® (a spray made from the patient's own skin cells) on the surgical site leads to better skin color matching than standard methods. About 20 adults having head and neck reconstructive surgery will take part. The goal is to see if this approach …
Matched conditions: HEAD AND NECK CANCER
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
Nose ointment may ease Radiation's brutal mouth pain
Symptom relief Not yet recruitingThis study tests whether a common antibiotic ointment applied inside the nose can reduce severe mouth and throat pain caused by radiation therapy in head and neck cancer patients. About 126 participants will receive either the antibiotic or a placebo, and neither they nor their d…
Matched conditions: HEAD AND NECK CANCER
Phase: PHASE2 • Sponsor: David Palma • Aim: Symptom relief
Last updated May 14, 2026 12:03 UTC
-
Could a ketamine mouthwash ease cancer treatment pain?
Symptom relief Not yet recruitingThis study tests if a ketamine oral rinse can relieve pain from mouth sores (mucositis) caused by radiation therapy in head and neck cancer patients. About 62 adults receiving radiation will use the rinse and report their pain levels. The goal is to see if this simple rinse impro…
Matched conditions: HEAD AND NECK CANCER
Phase: PHASE2 • Sponsor: University of Oklahoma • Aim: Symptom relief
Last updated May 13, 2026 16:03 UTC
-
Could less radiation be better for HPV throat cancer? new trial aims to find out
Symptom relief Not yet recruitingThis study tests whether lowering radiation doses to certain areas can reduce side effects for people with HPV-related oropharyngeal cancer, which often has good outcomes. About 132 participants will receive either reduced lymph node radiation, reduced tumor radiation, or both, b…
Matched conditions: HEAD AND NECK CANCER
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated May 13, 2026 16:01 UTC
-
Hearing shield: new drug may prevent Chemo-Induced hearing loss in adults
Symptom relief Not yet recruitingThis study tests whether a drug called Pedmark (sodium thiosulfate) can reduce hearing loss in adults receiving cisplatin chemotherapy for cancers like testicular, head and neck, or thoracic cancer. About 25 adults will receive Pedmark alongside their standard chemo to see if it …
Matched conditions: HEAD AND NECK CANCER
Phase: PHASE1, PHASE2 • Sponsor: University of Arizona • Aim: Symptom relief
Last updated May 11, 2026 20:52 UTC
-
Can a simple cream or dressing prevent radiation burns? new study aims to find out
Symptom relief Not yet recruitingThis study compares two skin-care approaches to prevent or reduce painful skin reactions caused by radiation therapy in head and neck cancer patients. About 104 adults receiving TomoTherapy will be randomly assigned to use either a moisturizing cream with a foam dressing or a sil…
Matched conditions: HEAD AND NECK CANCER
Phase: NA • Sponsor: King Faisal Specialist Hospital & Research Center • Aim: Symptom relief
Last updated May 04, 2026 16:19 UTC
-
AI could spot head and neck cancer earlier
Knowledge-focused Not yet recruitingThis study will use artificial intelligence to create a tool that predicts a person's risk of head and neck cancer. Researchers will analyze data from 3000 adults, including their medical history, lifestyle, and voice symptoms. The goal is to help doctors catch these cancers earl…
Matched conditions: HEAD AND NECK CANCER
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Knowledge-focused
Last updated May 16, 2026 23:49 UTC
-
Cancer biobank aims to unlock genomic secrets of lung and Head/Neck tumors
Knowledge-focused Not yet recruitingThis study collects blood and tissue samples from 110 adults with advanced lung, head/neck, or mesothelioma cancers. The samples will be stored in a biobank to help scientists study genetic changes and find better ways to predict treatment outcomes. Participants donate samples bu…
Matched conditions: HEAD AND NECK CANCER
Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated May 11, 2026 20:47 UTC
-
Chewing study aims to improve life after head and neck cancer
Knowledge-focused Not yet recruitingThis study follows 50 adults who have had head and neck cancer and now use a maxillofacial prosthesis (a custom-made artificial part for the face or mouth). Researchers will measure how well they chew, swallow, and speak, and how their quality of life changes over time. The goal …
Matched conditions: HEAD AND NECK CANCER
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated May 05, 2026 11:53 UTC
-
New CT scan could make cancer radiation planning quicker and cheaper
Knowledge-focused Not yet recruitingThis study tests whether a special type of CT scan (dual-energy CT) can be as good as MRI for outlining tumors and healthy organs before radiation therapy. About 80 adults with brain, bone, head/neck, or lung cancer will get both scans, and doctors will compare how accurately the…
Matched conditions: HEAD AND NECK CANCER
Sponsor: Aalborg University Hospital • Aim: Knowledge-focused
Last updated May 04, 2026 16:30 UTC